214 related articles for article (PubMed ID: 16672146)
21. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin system within the diabetic podocyte.
Márquez E; Riera M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
[TBL] [Abstract][Full Text] [Related]
24. Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.
Okabe M; Miyazaki Y; Niimura F; Pastan I; Nishiyama A; Yokoo T; Ichikawa I; Matsusaka T
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F932-7. PubMed ID: 25673808
[TBL] [Abstract][Full Text] [Related]
25. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
Moeller MJ
Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
[No Abstract] [Full Text] [Related]
26. Protecting podocytes: how good do we need to be?
Lemley KV
Kidney Int; 2012 Jan; 81(1):9-11. PubMed ID: 22170527
[TBL] [Abstract][Full Text] [Related]
27. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
28. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
[TBL] [Abstract][Full Text] [Related]
29. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
30. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
31. Regeneration of glomerular podocytes by human renal progenitors.
Ronconi E; Sagrinati C; Angelotti ML; Lazzeri E; Mazzinghi B; Ballerini L; Parente E; Becherucci F; Gacci M; Carini M; Maggi E; Serio M; Vannelli GB; Lasagni L; Romagnani S; Romagnani P
J Am Soc Nephrol; 2009 Feb; 20(2):322-32. PubMed ID: 19092120
[TBL] [Abstract][Full Text] [Related]
32. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
Cook HT
Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
Fukuda A; Wickman LT; Venkatareddy MP; Sato Y; Chowdhury MA; Wang SQ; Shedden KA; Dysko RC; Wiggins JE; Wiggins RC
Kidney Int; 2012 Jan; 81(1):40-55. PubMed ID: 21937979
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
35. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
37. Early-onset podocyte injury and glomerular sclerosis in osborne-mendel rats.
Yasuno K; Ishihara S; Saito R; Ishikawa M; Kato T; Kobayashi R; Baba T; Kawano K; Ogihara K; Kamiie J; Shirota K
J Vet Med Sci; 2010 Oct; 72(10):1319-27. PubMed ID: 20495300
[TBL] [Abstract][Full Text] [Related]
38. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury.
Papakrivopoulou E; Vasilopoulou E; Lindenmeyer MT; Pacheco S; Brzóska HŁ; Price KL; Kolatsi-Joannou M; White KE; Henderson DJ; Dean CH; Cohen CD; Salama AD; Woolf AS; Long DA
J Pathol; 2018 Dec; 246(4):485-496. PubMed ID: 30125361
[TBL] [Abstract][Full Text] [Related]
39. The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
Peten EP; Striker LJ; Fogo A; Ichikawa I; Patel A; Striker GE
Mol Med; 1994 Nov; 1(1):104-15. PubMed ID: 8790606
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
Darouich S; Goucha R; Jaafoura MH; Zekri S; Ben Maiz H; Kheder A
Ultrastruct Pathol; 2011 Aug; 35(4):176-82. PubMed ID: 21657818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
